• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

1435934-25-0 (A 419259 (trihydrochloride))

1

Identification

A 419259 (trihydrochloride) A 419259 (trihydrochloride)
Name A 419259 (trihydrochloride)
Formula C29H37Cl3N6O
MW 592.0
CAS No. 1435934-25-0
EINECS
Smiles NC1=C2C(N([[email protected]]3CC[[email protected]](N4CCN(C)CC4)CC3)C=C2C5=CC=C(OC6=CC=CC=C6)C=C5)=NC=N1.[H]Cl.[H]Cl.[H]Cl
Synonyms A419259 trihydrochloride;A-419259 trihydrochloride;RK 20449 trihydrochloride;RK20449 trihydrochloride;RK-20449 trihydrochloride; 7-((1r,4r)-4-(4-methylpiperazin-1-yl)cyclohexyl)-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine trihydrochloride
InChI InChI=1S/C29H34N6O.3ClH/c1-33-15-17-34(18-16-33)22-9-11-23(12-10-22)35-19-26(27-28(30)31-20-32-29(27)35)21-7-13-25(14-8-21)36-24-5-3-2-4-6-24;;;/h2-8,13-14,19-20,22-23H,9-12,15-18H2,1H3,(H2,30,31,32);3*1H/t22-,23-;;;
2

Introduction

A 419259 3Hcl is an apoptosis inducing agent that inhibits Src family kinases (c-Src).

Background Information

A 419259 3Hcl is an apoptosis inducing agent that inhibits Src family kinases (c-Src). A 419259 also induces apoptosis in CML cell ines and blocks Stat5 and Erk activation. IC50 Value: 9 nM (Src); <3 nM (Lck); <3 nM (Lyn); 3 uM (Abl) [1] Target: Src family kinase in vitro: Treatment of the Ph+ CML cell lines K-562 and Meg-01 with A-419259 resulted in growth arrest and induction of apoptosis, while the Ph- leukemia cell lines TF-1 and HEL were unaffected over the same concentration ranges. Suppression of Ph+ cell growth by A-419259 correlated with a decrease in Src kinase autophosphorylation. A-419259 blocked Stat5 and Erk activation, consistent with the suppressive effects of the compounds on survival and proliferation [1]. A-419259 treatment blocks all Src-family kinase activity in ES cells, preventing differentiation while maintaining pluripotency. Expression of inhibitor-resistant c-Src but not c-Yes rescued the A-419259 differentiation block, resulting in a cell population with properties of both primitive ectoderm and endoderm [2]. Blockade of Src family kinases using an Src-specific tyrosine kinase inhibitor A-419259 decreased GRP-induced EGFR phosphorylation and MAPK activation in HNSCC [3]. ......by MedChemexpress Co., Ltd.
3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance:White to off-white Solid EBNumber:EB000013722

Storage condition

Solubility

Soluble to 100 mM in water and to 100 mM in DMSO by MedChemexpress Co., Ltd.
5

Mechanism and Indication

Signaling Pathways Protein Tyrosine Kinase/RTK
Target Src
Research Area Cancer
Indications
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
A 419259 (trihydrochloride) - No Development Reported
7

Safety Data of A 419259 (trihydrochloride)

8

Spectral Information

9

Suppliers List

Company Price and Availability Country/Region
Apexbio Technology LLC 10mg/USD185(Ship Within 10-14 Days);50mg/USD551(Ship Within 10-14 Days) USA
CHEMSCENE, LLC USA
Cayman Chemical Company 1mg/USD35() USA
Key Organics Ltd. UK
MedChemexpress Co., Ltd. 10mg/USD180(In stock);50mg/USD630(In stock) USA
Santa Cruz Biotechnology, Inc. 5mg/USD138() USA
Shanghai Haoyuan Chemexpress Co., Ltd. 10mg/USD195(In stock);50mg/USD580(In stock) China
Tocris Bioscience Inc. 10mg/USD265() USA
10

Related Products

Other Forms of 1435934-25-0

Name CAS No Formula MW
A 419259 364042-47-7 C29H34N6O 482.62

Recommended Compounds in Src

Name CAS No Formula MW
Scutellarein 529-53-3 C15H10O6 286.24
A 419259 364042-47-7 C29H34N6O 482.62
1-Naphthyl PP1 221243-82-9 C19H19N5 317.39
XL228 898280-07-4 C22H31N9O 437.54
Dasatinib (hydrochloride) 854001-07-3 C22H27Cl2N7O2S 524.47
1-(2-Nitrovinyl)-3,4-methylenedioxybenzene 1485-00-3 C9H7NO4 193.16
PP2 172889-27-9 C15H16ClN5 301.77
PP1 172889-26-8 C16H19N5 281.36
ZM 306416 690206-97-4 C16H13ClFN3O2 333.74
AMG-47a 882663-88-9 C29H28F3N5O2 535.56
KX1-004 518058-84-9 C16H13FN2O2 284.29
AZM-475271 476159-98-5 C23H27ClN4O3 442.94
DCC-2036 1020172-07-9 C30H28FN7O3 553.59
Lck Inhibitor 847950-09-8 C31H30N8O 530.62
Lck inhibitor 2 944795-06-6 C18H17N5O2 335.36
PD173955 260415-63-2 C21H16Cl2N4OS 443.35
TG 100801 (Hydrochloride) 1018069-81-2 C33H31Cl2N5O3 616.54
TG 100801 867331-82-6 C33H30ClN5O3 580.08
TG 100572 (Hydrochloride) 867331-64-4 C26H27Cl2N5O2 512.43
TG 100572 867334-05-2 C26H26ClN5O2 475.97

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

13

More Information

A 419259 (trihydrochloride)

Tags: buy 1435934-25-0 IC50 | 1435934-25-0 price | 1435934-25-0 cost | 1435934-25-0 solubility | 1435934-25-0 purchase | 1435934-25-0 manufacturer | 1435934-25-0 research buy | 1435934-25-0 order | 1435934-25-0 MSDS | 1435934-25-0 chemical structure | 1435934-25-0 Storage condition | 1435934-25-0 molecular weight | 1435934-25-0 mw | 1435934-25-0 datasheet | 1435934-25-0 supplier | 1435934-25-0 cell line | 1435934-25-0 NMR | 1435934-25-0 MS | 1435934-25-0 IR | 1435934-25-0 solubility | 1435934-25-0 Safe information | 1435934-25-0 Qc and Spectral Information | 1435934-25-0 Clinical Information | 1435934-25-0 Clinical Trial | 1435934-25-0 Route of Synthesis | 1435934-25-0 storage condition | 1435934-25-0 diseases and conditions | 1435934-25-0 flash point | 1435934-25-0 boiling point | 1435934-25-0 melting point | 1435934-25-0 storage condition | 1435934-25-0 brand